Pancreatic Cancer Research

ResearcherThe Royal Free HospitalActive in the last 2 years

Daniel Osei‐Bordom

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4192-0730; OpenAlex author ID A5053436410. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 4

  1. Impact of tertiary lymphoid structures on prognosis and therapeutic response in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2024.04.009↗
  2. The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study. Co-author DOI 10.1038/s41416-023-02220-2↗
  3. Pancreatic ductal adenocarcinoma: Emerging therapeutic strategies. Co-author DOI 10.1016/j.suronc.2022.101803↗
  4. Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fmed.2021.788869↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Niki Christou · 1 shared paper, 2021 · strength 0.22
  2. Nabeel Merali · 1 shared paper, 2024 · strength 0.19
  3. Nicola E. Annels · 1 shared paper, 2024 · strength 0.19
  4. Tarak Agrebi Moumni Chouari · 1 shared paper, 2024 · strength 0.19
  5. Adam Enver Frampton · 1 shared paper, 2024 · strength 0.19
  6. Shivan Sivakumar · 1 shared paper, 2024 · strength 0.19
  7. Daniel Brock Hewitt · 1 shared paper, 2022 · strength 0.16
  8. Zachary J. Brown · 1 shared paper, 2022 · strength 0.16
  9. Timothy Michael Pawlik · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.